Skip to main content
. 2009 May 26;27(21):3465–3471. doi: 10.1200/JCO.2008.20.1301

Fig 2.

Fig 2.

Waterfall graph depicting the decrease in tumor measurements from baseline in patients treated with hepatic arterial infusion floxuridine/dexamethasone plus systemic oxaliplatin/irinotecan. −100 means 100% decrease in tumor. Blue bars represent patients who were not able to undergo resection. Gold bars represent patients who, though initially unresectable, after response with hepatic arterial infusion and systemic chemotherapy were able to undergo resection.